iSpecimen ( (ISPC) ) has released a notification of late filing.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
iSpecimen Inc. has notified regulators that it will be late in filing its Form 10-K (Yearly Report) for the financial year ended December 31, 2025, via a Form 12b-25. The delayed filing concerns its annual Form 10-K (Yearly Report), not any Form 10-Q (Quarter Report) or other periodic submissions.
The company cites a delay in obtaining and compiling certain information required for the Form 10-K (Yearly Report) as the reason for missing the deadline. Management says the delay could not be resolved without incurring unreasonable effort and expense, suggesting operational or reporting complexity rather than a disclosed control failure or auditor dispute.
iSpecimen expects to file the Form 10-K (Yearly Report) within the standard 15-calendar-day extension window allowed under SEC rules. Investors should therefore anticipate the annual report to be submitted on or before this extended due date, assuming no further issues arise.
The company does not expect any significant change in its results of operations compared with the prior fiscal year’s corresponding period, based on what it has disclosed so far. As with all forward-looking statements, this expectation may change once the full financial statements and accompanying disclosures are finalized and filed.
The filing notes that all other required periodic reports over the past 12 months have been submitted on time, indicating an otherwise compliant filing history. The notification is signed on behalf of iSpecimen Inc. by Chief Executive Officer Katharyn Field, underscoring management’s commitment to complete the Form 10-K (Yearly Report) and maintain regulatory compliance.
The most recent analyst rating on (ISPC) stock is a Sell with a $0.34 price target. To see the full list of analyst forecasts on iSpecimen stock, see the ISPC Stock Forecast page.
Spark’s Take on ISPC Stock
According to Spark, TipRanks’ AI Analyst, ISPC is a Neutral.
The score is weighed down primarily by weak financial performance (sharp TTM revenue decline, margin deterioration, ongoing losses, and persistent cash burn). Technicals add a mixed-to-weak backdrop (below key longer-term moving averages with negative MACD). Corporate events and valuation provide limited offset given Nasdaq bid-price compliance risk and a negative P/E tied to ongoing losses.
To see Spark’s full report on ISPC stock, click here.
More about iSpecimen
Average Trading Volume: 7,543,504
Technical Sentiment Signal: Strong Sell
Current Market Cap: $1.41M
For detailed information about ISPC stock, go to TipRanks’ Stock Analysis page.